Pharmafile Logo
Pharmafocus logo
Advanced Search

BC-821

Showing 1 posts of 1 posts found.

Cobra biologics image

Cobra agrees oncology deal with BioCancell

March 4, 2014
Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology

Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025